PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Leuven research opens new pathway for the treatment of Alzheimer's disease

2012-12-03
(Press-News.org) Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease. There is currently no cure for this disease. Many candidate drugs fail because they also target proteins essential to life. This discovery from Leuven could form a target for a treatment against Alzheimer's disease with fewer side effects and that suppresses the very first symptoms of the disease. This research will be published in the leading journal Nature Medicine.

Alzheimer's Disease Alzheimer's Disease is the most common form of dementia in the West. The damage to memory and mental function causes one of the most terrifying clinical pictures. The current drugs for Alzheimer patients support memory for a short time, but they do not stop the death of brain cells. Recent insights have shown that Alzheimer's disease causes biochemical changes in the brain many years before the symptoms of dementia are present. It is very important to develop drugs that can be taken at this early stage in order to prevent the disease.

The ɣ-secretase complex Many candidate drugs have an effect on the ɣ-secretase complex. This complex cuts proteins at specific sites and plays an important role in the development of amyloid plaques, a pathological hallmark in of the brains of Alzheimer patients. Aberrant and excessive cleavage of the amyloid precursor protein by the y-secretase complex results in the accumulation and deposition of the β-amyloid protein in amyloid plaques.

However, the ɣ-secretase complex is also involved in cleavage of a series of other proteins essential to life. As a result, many candidate drugs that act on the ɣ-secretase complex produce toxic side effects.

GPCRs and β-arrestin GPCRs are a family of proteins that serve as the targets of the majority of all currently marketed drugs. The Nobel Prize in Chemistry for 2012 was awarded to Dr. Robert Lefkowitz and Dr. Brian Kobilka for their groundbreaking work in this field and the many medical applications of this knowledge. It is known that GPCRs also play a role in the development of Alzheimer's disease, but it is not yet clear how GPCRs regulate the ɣ-secretase complex.

β-arrestins are a family of proteins that classically block or limit GPCR activation; however, it has been recently appreciated that β-arrestins also have additional functions. Therefore, Amantha Thathiah set up a study under the supervision of Bart De Strooper to examine the involvement of β-arrestins in the development of Alzheimer's disease.

The scientists succeeded for the first time in demonstrating that β-arrestin 2 plays a role in regulation of the ɣ-secretase complex function and in the development of Alzheimer's disease in an Alzheimer's disease mouse model. More specifically, β-arrestin 2 interacts with two GPCRs that are known to play a role in the development of Alzheimer's disease. Moreover, expression of β-arrestin 2 is also elevated in individuals with Alzheimer's disease.

Impact of the research This research opens a new pathway for the treatment of Alzheimer's disease. β-arrestin 2 inhibition could be beneficial in prevention of the adverse side effects currently associated with γ-secretase inhibition. Therefore, this study provides a previously unexplored avenue for the development of a treatment that can act at a very early stage of Alzheimer's disease.

### Questions Given that this research can raise many questions of patients, we would like to refer you to the email address that VIB makes available for this purpose. Anyone can submit questions concerning this and other medically oriented research to patienteninfo@vib.be.

Relevant scientific publication This research will be published in the leading journal Nature Medicine, Thathiah et al., β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease

Study team This research was performed in the research group of Bart De Strooper in the VIB Research Centre for Developmental Mechanisms of Diseases, KU Leuven

Funding This research was funded by VIB, MNIRG from the Alzheimer's Association, the Fund for Scientific Research Flanders, K.U. Leuven, a Methusalem grant from the K.U. Leuven and the Flemish government, the foundation for Alzheimer Research (SAO/FRMA).


ELSE PRESS RELEASES FROM THIS DATE:

Uncovering unique properties in a 2-dimensional crystal

2012-12-03
When the dry lubricant, molybdenum disulfide, is stripped down to a single layer of atoms, a tightly bound quasi-particle comprised of two electrons and a hole forms with unique spin and valley properties, researchers from Case Western Reserve University and colleagues discovered. These charged quasi-particles, called negative trions, can be manipulated to change the light absorbed and emitted from this two-dimensional semi-conducting crystal, opening it to potential use in new solar cells and other electronic devices that are controlled by light or designed to control ...

Sharp spike in computer-related injuries predicted for medical workers, find studies

2012-12-03
ITHACA, N.Y. – As U.S. health care goes high tech, spurred by $20 billion in federal stimulus incentives, the widespread adoption of electronic medical records and related digital technologies is predicted to reduce errors and lower costs – but it is also likely to significantly boost musculoskeletal injuries among doctors and nurses, concludes a Cornell University ergonomics professor in two new papers. The repetitive strain injuries, he said, will stem from poor office layouts and improper use of computer devices. "Many hospitals are investing heavily in new technology ...

Cancer screening: The efficacy of mammography screening

2012-12-03
How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North Rhine–Westphalia and his co-authors in the first study on this subject in Germany, in Deutsches Ärzteblatt International (Dtsch Arztebl Int 2012; 109(46): 781-7). To answer it, the authors have used the interval cancer rate as an indicator. Interval cancers are tumors found more or less by chance between two screenings. In approximately 880 000 women from North Rhine–Westphalia who had taken part in mammography screening ...

New 'pipeline' device offers new option for difficult-to-treat aneurysms

2012-12-03
Philadelphia, Pa. (December 3, 2012) – A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Data collected since the PED was approved for marketing show generally good results in "real world" clinical practice. However, the report raises concerns about fatal bleeding and other ...

Novel antibodies for combating Alzheimer's and Parkinson's disease

Novel antibodies for combating Alzheimers and Parkinsons disease
2012-12-03
Troy, N.Y. – Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study. The onset of these devastating diseases is associated with the inappropriate clumping of proteins into particles that are harmful to cells in the brain (Alzheimer's disease and Parkinson's disease) and pancreas (Type 2 diabetes). Antibodies, which are commonly used by the immune system to target foreign ...

Awareness is key to preventing heat- and cold-induced athletic injuries

2012-12-03
ROSEMONT, Ill.—Extreme heat or cold can cause dangerous and potentially fatal side effects in athletes. A literature review appearing in the December 2012 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) provides an overview of the risk factors, signs and symptoms, and management of various conditions related to excessive heat and cold exposure. "Both extreme heat and cold can be challenging for athletes during training and competition," said lead study author Benjamin Noonan, MD, MS. "One role of the team physician is to educate coaches and ...

Squirrels and birds inspire researchers to create deceptive robots

Squirrels and birds inspire researchers to create deceptive robots
2012-12-03
Using deceptive behavioral patterns of squirrels and birds, researchers at the Georgia Institute of Technology have developed robots that are able to deceive each other. The research is funded by the Office of Naval Research and is led by Professor Ronald Arkin, who suggests the applications could be implemented by the military in the future. The research is highlighted in the November/December 2012 edition of IEEE Intelligent Systems. Arkin and his team learned by reviewing biological research results that squirrels gather acorns and store them in specific locations. ...

College students report low flu vaccine rate

2012-12-03
WINSTON-SALEM, N.C. – Dec. 3, 2012 – College football and basketball games may provide more than a way for students to show school spirit – they could help prevent the flu. According to a new study by researchers at Wake Forest Baptist Medical Center, colleges and universities should implement new or improved influenza vaccine strategies, such as giving flu shots at sporting events or during campus-wide, day-long campaigns, to increase the number of their students who get the annual flu vaccine. In the early online edition of the December issue of the Journal of American ...

PET imaging used to more accurately manage treatment, predict survival for patients with gliomas

2012-12-03
Reston, Va. (December 3, 2012) – In the management of gliomas—or tumors that originate in the brain—precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival. Research published in the December issue of The Journal of Nuclear Medicine (JNM) highlights the potential of imaging with 3'-deoxy-3'-F-18-fluorothymidine (F-18-FLT) positron emission tomography (PET) to noninvasively and accurately provide tumor-specific details to guide management of patients with gliomas. Gliomas ...

Iron deficiency and cognitive development: New insights from piglets

2012-12-03
University of Illinois researchers have developed a model that uses neonatal piglets for studying infant brain development and its effect on learning and memory. To determine if the model is nutrient-sensitive, they have done some research on the effects of iron-deficient diets. "Iron deficiency is a major problem worldwide," said Rodney Johnson, professor of animal sciences and director of the Division of Nutritional Sciences. "Infants who experience iron deficiency during the first 6 to 12 months of age can have irreversible developmental delays in cognition." He ...

LAST 30 PRESS RELEASES:

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

[Press-News.org] Leuven research opens new pathway for the treatment of Alzheimer's disease